NCT00005926View on ClinicalTrials.gov

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

December 31, 2000

Conditions
Pancreatic CancerPancreatic Neoplasm
Interventions
DRUG

Gemcitabine

DRUG

Herceptin

PROCEDURE

Radiation therapy

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00005926 - Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | Biotech Hunter | Biotech Hunter